TW200600785A - Method for diagnosing non-small cell lung cancer - Google Patents
Method for diagnosing non-small cell lung cancerInfo
- Publication number
- TW200600785A TW200600785A TW094108342A TW94108342A TW200600785A TW 200600785 A TW200600785 A TW 200600785A TW 094108342 A TW094108342 A TW 094108342A TW 94108342 A TW94108342 A TW 94108342A TW 200600785 A TW200600785 A TW 200600785A
- Authority
- TW
- Taiwan
- Prior art keywords
- lung cancer
- small cell
- cell lung
- diagnosing non
- ghsr1b
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/731—Carrageenans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/136—Screening for pharmacological compounds
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US55578904P | 2004-03-23 | 2004-03-23 |
Publications (1)
Publication Number | Publication Date |
---|---|
TW200600785A true TW200600785A (en) | 2006-01-01 |
Family
ID=34961862
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW094108342A TW200600785A (en) | 2004-03-23 | 2005-03-18 | Method for diagnosing non-small cell lung cancer |
Country Status (9)
Country | Link |
---|---|
US (3) | US7700573B2 (zh) |
EP (2) | EP2343384A3 (zh) |
JP (2) | JP4938451B2 (zh) |
CN (1) | CN1977052B (zh) |
AT (1) | ATE496142T1 (zh) |
DE (1) | DE602005025998D1 (zh) |
ES (1) | ES2360073T3 (zh) |
TW (1) | TW200600785A (zh) |
WO (1) | WO2005090603A2 (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9073968B2 (en) | 2007-08-20 | 2015-07-07 | Oncotherapy Science, Inc. | FOXM1 peptide and medicinal agent comprising the same |
Families Citing this family (82)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0307428D0 (en) | 2003-03-31 | 2003-05-07 | Medical Res Council | Compartmentalised combinatorial chemistry |
GB0307403D0 (en) | 2003-03-31 | 2003-05-07 | Medical Res Council | Selection by compartmentalised screening |
US20060078893A1 (en) | 2004-10-12 | 2006-04-13 | Medical Research Council | Compartmentalised combinatorial chemistry by microfluidic control |
US20050221339A1 (en) | 2004-03-31 | 2005-10-06 | Medical Research Council Harvard University | Compartmentalised screening by microfluidic control |
US7968287B2 (en) | 2004-10-08 | 2011-06-28 | Medical Research Council Harvard University | In vitro evolution in microfluidic systems |
US7998695B2 (en) | 2005-02-10 | 2011-08-16 | Oncotherapy Science, Inc. | Method of diagnosing bladder cancer |
DK2325305T3 (en) * | 2005-02-25 | 2014-03-03 | Oncotherapy Science Inc | Peptide vaccines for cancers that express TTK-, URLC10- or KOC1 polypeptide |
US20070082845A1 (en) * | 2005-07-15 | 2007-04-12 | The Penn State Research Foundation | Ferritin as a therapeutic target in abnormal cells |
EP2311985A1 (en) | 2005-07-27 | 2011-04-20 | Oncotherapy Science, Inc. | Sirna for treating esophageal cancer |
US9347945B2 (en) | 2005-12-22 | 2016-05-24 | Abbott Molecular Inc. | Methods and marker combinations for screening for predisposition to lung cancer |
WO2007081386A2 (en) | 2006-01-11 | 2007-07-19 | Raindance Technologies, Inc. | Microfluidic devices and methods of use |
WO2007097469A1 (en) * | 2006-02-24 | 2007-08-30 | Oncotherapy Science, Inc. | A dominant negative peptide of imp-3, polynucleotide encoding the same, pharmaceutical composition containing the same, and methods for treating or preventing cancer |
JP2009536516A (ja) * | 2006-04-20 | 2009-10-15 | オンコセラピー・サイエンス株式会社 | 肺癌の治療標的としてのNMU−GHSR1b/NTSR1発癌シグナル伝達経路 |
EP2481815B1 (en) | 2006-05-11 | 2016-01-27 | Raindance Technologies, Inc. | Microfluidic devices |
US9562837B2 (en) | 2006-05-11 | 2017-02-07 | Raindance Technologies, Inc. | Systems for handling microfludic droplets |
WO2008021123A1 (en) | 2006-08-07 | 2008-02-21 | President And Fellows Of Harvard College | Fluorocarbon emulsion stabilizing surfactants |
US20110070245A1 (en) * | 2006-08-18 | 2011-03-24 | Oncotherapy Science Inc. | Imp-1 oncogene as a therapeutic target and prognostic indicator for lung cancer |
EP2061900A2 (en) | 2006-08-25 | 2009-05-27 | Oncotherapy Science, Inc. | Prognostic markers and therapeutic targets for lung cancer |
ES2372217T3 (es) * | 2006-09-12 | 2012-01-17 | Genentech, Inc. | Procedimientos y composiciones para el diagnóstico y tratamiento del cáncer de pulmón utilizando el gen de pdgfra, kit o kdr como marcador genético. |
US8772046B2 (en) | 2007-02-06 | 2014-07-08 | Brandeis University | Manipulation of fluids and reactions in microfluidic systems |
US8592221B2 (en) | 2007-04-19 | 2013-11-26 | Brandeis University | Manipulation of fluids, fluid components and reactions in microfluidic systems |
CA2697517A1 (en) * | 2007-08-24 | 2009-03-05 | Oncotherapy Science, Inc. | Cancer-related genes, cdca5, epha7, stk31 and wdhd1 |
JP2010536366A (ja) * | 2007-08-24 | 2010-12-02 | オンコセラピー・サイエンス株式会社 | 肺癌の治療及び診断の標的遺伝子のためのebi3、dlx5、nptx1、及びcdkn3 |
RU2010111116A (ru) * | 2007-08-24 | 2011-09-27 | Онкотерапи Сайенс, Инк. (Jp) | Pkib и naaladl2 в качестве генов-мишеней в терапии и диагностике рака предстательной железы |
US8541183B2 (en) | 2007-09-11 | 2013-09-24 | Cancer Prevention And Cure, Ltd. | Methods of identification, assessment, prevention and therapy of lung diseases and kits thereof |
EP2060583A1 (en) | 2007-10-23 | 2009-05-20 | Ganymed Pharmaceuticals AG | Identification of tumor-associated markers for diagnosis and therapy |
US9670551B2 (en) | 2007-11-30 | 2017-06-06 | Genomictree, Inc. | Diagnosis kit and chip for bladder cancer using bladder cancer specific methylation marker gene |
US9783857B2 (en) | 2007-11-30 | 2017-10-10 | Genomictree, Inc. | Diagnosis kit and chip for bladder cancer using bladder cancer specific methylation marker gene |
US10113203B2 (en) | 2007-11-30 | 2018-10-30 | Genomictree, Inc. | Diagnosis kit and chip for bladder cancer using bladder cancer specific methylation marker gene |
US9797017B2 (en) | 2007-11-30 | 2017-10-24 | Genomictree, Inc. | Diagnosis kit and chip for bladder cancer using bladder cancer specific methylation marker gene |
CN101878315A (zh) | 2007-11-30 | 2010-11-03 | 基因特力株式会社 | 使用膀胱癌特异性甲基化标记基因的膀胱癌诊断试剂盒和芯片 |
US9670552B2 (en) | 2007-11-30 | 2017-06-06 | Genomictree, Inc. | Diagnosis kit and chip for bladder cancer using bladder cancer specific methylation marker gene |
US8529900B2 (en) | 2008-04-16 | 2013-09-10 | Inserm (Institut National De La Sante Et De La Recherche Medicale) | Methods for the treatment, the prognostic assessment and the staging of non-small cell lung cancer |
EP2297581B1 (en) | 2008-07-03 | 2013-04-03 | F. Hoffmann-La Roche AG | Asc as a marker for lung cancer |
EP2321410A4 (en) * | 2008-07-16 | 2011-09-14 | Oncotherapy Science Inc | ONCOGEN ECT2 AS A THERAPEUTIC TARGET AND PROGNOSTIC INDICATOR FOR LUNG AND SOPHAGE CANCER |
EP2145964A1 (en) * | 2008-07-17 | 2010-01-20 | Universität Zu Köln | A method for lung cancer early detection and prognosis |
EP4047367A1 (en) | 2008-07-18 | 2022-08-24 | Bio-Rad Laboratories, Inc. | Method for detecting target analytes with droplet libraries |
KR20110063490A (ko) * | 2008-08-27 | 2011-06-10 | 온코세라피 사이언스 가부시키가이샤 | 암 치료 및 진단의 표적 유전자인 syngr4 |
ES2559758T3 (es) * | 2008-09-09 | 2016-02-15 | Somalogic, Inc. | Biomarcadores de cáncer de pulmón y usos de los mismos |
WO2010037856A2 (en) * | 2008-10-03 | 2010-04-08 | Stichting Katholieke Universiteit, Universitair Medisch Centrum St. Radboud | DYNACTIN-1/p150glued AS A TARGET FOR TUMOR DIAGNOSIS AND THERAPY AND A METHOD FOR IDENTIFYING TARGETABLE DISEASE-RELATED PROTEINS |
WO2010079158A1 (en) * | 2009-01-07 | 2010-07-15 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods for the treatment, the prognostic assessment and the detection of breast cancer |
TWI469791B (zh) * | 2009-02-18 | 2015-01-21 | Oncotherapy Science Inc | Foxm1胜肽以及含此胜肽之疫苗 |
EP3444359A1 (en) * | 2009-03-12 | 2019-02-20 | Cancer Prevention And Cure, Ltd. | Methods of identification of non-small cell lung cancer |
WO2010111231A1 (en) | 2009-03-23 | 2010-09-30 | Raindance Technologies, Inc. | Manipulation of microfluidic droplets |
EP2486409A1 (en) | 2009-10-09 | 2012-08-15 | Universite De Strasbourg | Labelled silica-based nanomaterial with enhanced properties and uses thereof |
EP2517025B1 (en) | 2009-12-23 | 2019-11-27 | Bio-Rad Laboratories, Inc. | Methods for reducing the exchange of molecules between droplets |
JP5934657B2 (ja) | 2010-02-12 | 2016-06-15 | レインダンス テクノロジーズ, インコーポレイテッド | デジタル検体分析 |
US10351905B2 (en) | 2010-02-12 | 2019-07-16 | Bio-Rad Laboratories, Inc. | Digital analyte analysis |
US9399797B2 (en) | 2010-02-12 | 2016-07-26 | Raindance Technologies, Inc. | Digital analyte analysis |
US9366632B2 (en) | 2010-02-12 | 2016-06-14 | Raindance Technologies, Inc. | Digital analyte analysis |
GB201004551D0 (en) | 2010-03-19 | 2010-05-05 | Immatics Biotechnologies Gmbh | NOvel immunotherapy against several tumors including gastrointestinal and gastric cancer |
EP2622103B2 (en) | 2010-09-30 | 2022-11-16 | Bio-Rad Laboratories, Inc. | Sandwich assays in droplets |
EP3412778A1 (en) | 2011-02-11 | 2018-12-12 | Raindance Technologies, Inc. | Methods for forming mixed droplets |
EP3736281A1 (en) | 2011-02-18 | 2020-11-11 | Bio-Rad Laboratories, Inc. | Compositions and methods for molecular labeling |
DE202012013668U1 (de) | 2011-06-02 | 2019-04-18 | Raindance Technologies, Inc. | Enzymquantifizierung |
US8841071B2 (en) | 2011-06-02 | 2014-09-23 | Raindance Technologies, Inc. | Sample multiplexing |
US8658430B2 (en) | 2011-07-20 | 2014-02-25 | Raindance Technologies, Inc. | Manipulating droplet size |
CN103857804A (zh) * | 2011-08-03 | 2014-06-11 | 西格诺药品有限公司 | 作为lkb1状态的预测性生物标志物的基因表达谱的鉴定 |
GB2496150A (en) * | 2011-11-02 | 2013-05-08 | Provost Fellows & Scholars College Of The Holy Undivided Trinity Of Queen Elizabeth Near Dublin | Biomarker and target for responsiveness and resistance to cancer targeting agents |
US20130210659A1 (en) | 2012-02-10 | 2013-08-15 | Andrew Watson | Molecular diagnostic screening assay |
WO2013165748A1 (en) | 2012-04-30 | 2013-11-07 | Raindance Technologies, Inc | Digital analyte analysis |
AU2014227891A1 (en) * | 2013-03-15 | 2015-10-08 | Sera Prognostics, Inc. | Biomarkers and methods for predicting preterm birth |
JP2014207883A (ja) * | 2013-03-27 | 2014-11-06 | 国立大学法人岡山大学 | がん幹細胞及びその用途 |
EP2986762B1 (en) | 2013-04-19 | 2019-11-06 | Bio-Rad Laboratories, Inc. | Digital analyte analysis |
TWI643867B (zh) | 2013-05-24 | 2018-12-11 | 日商腫瘤療法 科學股份有限公司 | 對於th1細胞之imp-3抗原決定位胜肽及含此之疫苗 |
EP3035935B1 (en) * | 2013-08-19 | 2020-03-11 | F. Hoffmann-La Roche AG | Compounds for use in the prophylaxis and treatment of cancer |
US11901041B2 (en) | 2013-10-04 | 2024-02-13 | Bio-Rad Laboratories, Inc. | Digital analysis of nucleic acid modification |
US9944977B2 (en) | 2013-12-12 | 2018-04-17 | Raindance Technologies, Inc. | Distinguishing rare variations in a nucleic acid sequence from a sample |
WO2015103367A1 (en) | 2013-12-31 | 2015-07-09 | Raindance Technologies, Inc. | System and method for detection of rna species |
US10576102B2 (en) | 2014-08-04 | 2020-03-03 | Oncotherapy Science, Inc. | KOC1-derived peptide and vaccine including same |
IL256399B (en) | 2015-06-19 | 2022-09-01 | Sera Prognostics Inc | Pairs of biomarkers for predicting premature birth |
CN107828871A (zh) * | 2015-06-24 | 2018-03-23 | 湖北工业大学 | 基于肽核酸探针的Wnt信号通路中FoxM1基因P271Q突变的检测试剂 |
US10647981B1 (en) | 2015-09-08 | 2020-05-12 | Bio-Rad Laboratories, Inc. | Nucleic acid library generation methods and compositions |
CN112940076A (zh) | 2015-10-08 | 2021-06-11 | 肿瘤疗法科学股份有限公司 | Foxm1衍生的肽和包含它们的疫苗 |
EP3487998B1 (en) | 2016-07-19 | 2023-07-12 | Brandeis University | Compositions and methods for identifying rna binding polypeptide targets |
JP7250693B2 (ja) | 2017-04-04 | 2023-04-03 | ラング キャンサー プロテオミクス, エルエルシー | 初期ステージの肺がん診断のための血漿ベースのタンパク質プロファイリング |
EP3668996A4 (en) | 2017-08-18 | 2021-04-21 | Sera Prognostics, Inc. | CLOCK PREGNANCY PROTEIN FOR PREDICTING THE DATE AND TIME TO BIRTH |
US10998178B2 (en) | 2017-08-28 | 2021-05-04 | Purdue Research Foundation | Systems and methods for sample analysis using swabs |
CN111317743B (zh) * | 2020-03-13 | 2022-11-29 | 中国人民解放军第四军医大学 | 一种基于Kif11基因的重组腺相关病毒抑制病理性疼痛的应用 |
TWI781647B (zh) * | 2020-06-09 | 2022-10-21 | 財團法人國家衛生研究院 | 抗人神經降壓素受體抗體及其用途 |
CN114561358B (zh) * | 2022-03-09 | 2023-10-03 | 广州源井生物科技有限公司 | 一种提高细胞慢病毒感染率的增强感染培养基及方法 |
CN115478106B (zh) * | 2022-08-18 | 2023-07-07 | 南方医科大学南方医院 | 一种基于lr对对三阴性乳腺癌进行分型的方法及其应用 |
Family Cites Families (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5223409A (en) | 1988-09-02 | 1993-06-29 | Protein Engineering Corp. | Directed evolution of novel binding proteins |
GB8823869D0 (en) | 1988-10-12 | 1988-11-16 | Medical Res Council | Production of antibodies |
US5744101A (en) | 1989-06-07 | 1998-04-28 | Affymax Technologies N.V. | Photolabile nucleoside protecting groups |
US6150584A (en) | 1990-01-12 | 2000-11-21 | Abgenix, Inc. | Human antibodies derived from immunized xenomice |
US5545806A (en) | 1990-08-29 | 1996-08-13 | Genpharm International, Inc. | Ransgenic non-human animals for producing heterologous antibodies |
US5661016A (en) | 1990-08-29 | 1997-08-26 | Genpharm International Inc. | Transgenic non-human animals capable of producing heterologous antibodies of various isotypes |
US5625126A (en) | 1990-08-29 | 1997-04-29 | Genpharm International, Inc. | Transgenic non-human animals for producing heterologous antibodies |
US5633425A (en) | 1990-08-29 | 1997-05-27 | Genpharm International, Inc. | Transgenic non-human animals capable of producing heterologous antibodies |
ES2108048T3 (es) | 1990-08-29 | 1997-12-16 | Genpharm Int | Produccion y utilizacion de animales inferiores transgenicos capaces de producir anticuerpos heterologos. |
EP0746609A4 (en) | 1991-12-17 | 1997-12-17 | Genpharm Int | NON-HUMAN TRANSGENIC ANIMALS CAPABLE OF PRODUCING HETEROLOGOUS ANTIBODIES |
WO1994002602A1 (en) | 1992-07-24 | 1994-02-03 | Cell Genesys, Inc. | Generation of xenogeneic antibodies |
AU6819494A (en) | 1993-04-26 | 1994-11-21 | Genpharm International, Inc. | Transgenic non-human animals capable of producing heterologous antibodies |
AU5632296A (en) | 1995-04-27 | 1996-11-18 | Abgenix, Inc. | Human antibodies derived from immunized xenomice |
WO1996034096A1 (en) | 1995-04-28 | 1996-10-31 | Abgenix, Inc. | Human antibodies derived from immunized xenomice |
US5889170A (en) * | 1997-01-31 | 1999-03-30 | Incyte Pharmaceuticals, Inc. | Human integral membrane protein |
US6506559B1 (en) * | 1997-12-23 | 2003-01-14 | Carnegie Institute Of Washington | Genetic inhibition by double-stranded RNA |
US6297364B1 (en) * | 1998-04-17 | 2001-10-02 | Ludwig Institute For Cancer Research | Isolated nucleic acid molecule encoding cancer associated antigen, the antigen itself, and uses thereof |
US20020103360A1 (en) | 1998-09-01 | 2002-08-01 | Yang Pan | Novel protein related to melanoma-inhibiting protein and uses thereof |
AU2342900A (en) * | 1998-09-23 | 2000-05-01 | Cleveland Clinic Foundation, The | Novel interferon stimulated and repressed genes |
WO2000063353A1 (en) * | 1999-04-20 | 2000-10-26 | Cytokinetics | Human kinesins and methods of producing and purifying human kinesins |
DE19935303A1 (de) * | 1999-07-28 | 2001-02-08 | Aventis Pharma Gmbh | Oligonukleotide zur Inhibierung der Expression von humanem eg5 |
US6617115B1 (en) * | 1999-10-27 | 2003-09-09 | Cytokinetics, Inc. | Methods of screening for modulators of cell proliferation |
JP2004509612A (ja) * | 2000-06-05 | 2004-04-02 | アバロン ファーマシューティカルズ | ガン遺伝子決定および特徴的な遺伝子群を用いた治療用スクリーニング |
US7358353B2 (en) * | 2000-08-22 | 2008-04-15 | Agensys, Inc. | Nucleic acid and corresponding protein named 158P1D7 useful in the treatment and detection of bladder and other cancers |
US6706867B1 (en) * | 2000-12-19 | 2004-03-16 | The United States Of America As Represented By The Department Of Health And Human Services | DNA array sequence selection |
IL158083A0 (en) * | 2001-03-29 | 2004-03-28 | Bristol Myers Squibb Co | A PHARMACEUTICAL COMPOSITION CONTAINING AN Eg5 PROTEIN INHIBITOR |
JP2005503145A (ja) | 2001-08-16 | 2005-02-03 | ザ ユナイテッド ステイツ オブ アメリカ リプレゼンティッド バイ ザ シークレタリー デパートメント オブ ヘルス アンド ヒューマン サービシーズ | 非小細胞肺癌の分子特性 |
US20040009156A1 (en) | 2001-10-12 | 2004-01-15 | Christoph Reinhard | Antisense therapy using oligonucleotides that target human kinesin genes for treatment of cancer |
US7163927B2 (en) * | 2002-05-23 | 2007-01-16 | Isis Pharmaceuticals, Inc. | Antisense modulation of kinesin-like 1 expression |
EP1560931B1 (en) * | 2002-11-14 | 2011-07-27 | Dharmacon, Inc. | Functional and hyperfunctional sirna |
AU2004286261B2 (en) * | 2003-10-27 | 2010-06-24 | Merck Sharp & Dohme Llc | Method of designing siRNAs for gene silencing |
AU2005213464A1 (en) * | 2004-02-06 | 2005-08-25 | Wyeth | Diagnosis and therapeutics for cancer |
-
2005
- 2005-03-18 JP JP2006526453A patent/JP4938451B2/ja not_active Expired - Fee Related
- 2005-03-18 TW TW094108342A patent/TW200600785A/zh unknown
- 2005-03-18 ES ES05721540T patent/ES2360073T3/es active Active
- 2005-03-18 AT AT05721540T patent/ATE496142T1/de not_active IP Right Cessation
- 2005-03-18 WO PCT/JP2005/005613 patent/WO2005090603A2/en active Application Filing
- 2005-03-18 EP EP10177195A patent/EP2343384A3/en not_active Withdrawn
- 2005-03-18 DE DE602005025998T patent/DE602005025998D1/de active Active
- 2005-03-18 EP EP05721540A patent/EP1737979B9/en not_active Not-in-force
- 2005-03-18 CN CN2005800165605A patent/CN1977052B/zh not_active Expired - Fee Related
- 2005-03-18 US US10/593,842 patent/US7700573B2/en not_active Expired - Fee Related
-
2010
- 2010-02-04 US US12/700,669 patent/US7972772B2/en not_active Expired - Fee Related
- 2010-09-24 JP JP2010212951A patent/JP2011039069A/ja not_active Withdrawn
-
2011
- 2011-05-23 US US13/113,732 patent/US20110223687A1/en not_active Abandoned
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9073968B2 (en) | 2007-08-20 | 2015-07-07 | Oncotherapy Science, Inc. | FOXM1 peptide and medicinal agent comprising the same |
US9415096B2 (en) | 2007-08-20 | 2016-08-16 | OncoTherapy Sciences, Inc. | FOXM1 peptide and medicinal agent comprising the same |
TWI558411B (zh) * | 2007-08-20 | 2016-11-21 | Oncotherapy Science Inc | FOXM1 peptides and agents containing this peptide |
Also Published As
Publication number | Publication date |
---|---|
US7972772B2 (en) | 2011-07-05 |
WO2005090603A3 (en) | 2006-03-02 |
US7700573B2 (en) | 2010-04-20 |
EP2343384A2 (en) | 2011-07-13 |
US20110223687A1 (en) | 2011-09-15 |
CN1977052B (zh) | 2012-09-05 |
US20100173317A1 (en) | 2010-07-08 |
WO2005090603A2 (en) | 2005-09-29 |
JP4938451B2 (ja) | 2012-05-23 |
ES2360073T3 (es) | 2011-05-31 |
US20080050378A1 (en) | 2008-02-28 |
DE602005025998D1 (de) | 2011-03-03 |
EP2343384A3 (en) | 2012-01-04 |
ATE496142T1 (de) | 2011-02-15 |
CN1977052A (zh) | 2007-06-06 |
JP2007530006A (ja) | 2007-11-01 |
EP1737979A2 (en) | 2007-01-03 |
EP1737979B1 (en) | 2011-01-19 |
JP2011039069A (ja) | 2011-02-24 |
EP1737979B9 (en) | 2011-09-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TW200600785A (en) | Method for diagnosing non-small cell lung cancer | |
WO2009075799A3 (en) | Method for diagnosing lung cancers using gene expression profiles in peripheral blood mononuclear cells | |
WO2010051314A3 (en) | Genomic classification of non-small cell lung carcinoma based on patterns of gene copy number alterations | |
WO2006008128A3 (en) | Epigenetic methods and nucleic acids for the detection of breast cell proliferative disorders | |
MX2007012782A (es) | Metodos y acidos nucleicos para analisis de trastornos proliferativos celulares. | |
WO2003021227A3 (en) | Methods and compositions useful for diagnosis, staging, and treatment of cancers and tumors | |
WO2003076593A3 (en) | Genomic screen for epigenetically silenced genes associated with cancer | |
WO2001094629A8 (en) | Cancer gene determination and therapeutic screening using signature gene sets | |
ATE483979T1 (de) | Gen anln in verbindung mit nicht-kleinzelligem lungenkrebs und seine wechselwirkungen mit rhoa | |
WO2007084992A3 (en) | Prognosis and therapy predictive markers and methods of use | |
HK1121193A1 (en) | Improved methods for beaming | |
WO2006007479A3 (en) | Method for enumerating mammalian cell micronuclei via differential staining | |
WO2006047536A3 (en) | Methods and kits for detecting mutations | |
WO2006034456A3 (en) | Compositions and methods for detecting and treating tumors | |
WO2006034879A3 (en) | Epigenetic methods and nucleic acids for the detection of lung cell proliferative disorders | |
WO2005085863A3 (en) | Biomarker: compound correlations in cancer diagnosis and therapy | |
AU2003253440A1 (en) | Method of diagnosing ovarian endometriosis | |
WO2009003706A3 (en) | Methods, kits, and compounds for determining responsiveness to treatment of a pathological disorder by epothilones | |
WO2006028999A3 (en) | Assessment of ctla-4 polymorphisms in ctla-4 blockade therapy | |
WO2005001141A8 (en) | Methods and nucleic acids for analyses of colorectal cell proliferative disorders | |
PT1529116E (pt) | Métodos para o tratamento da demência com base no genótipo da apo e | |
Benoy et al. | Prognostic significance of disseminated tumor cells as detected by quantitative real-time reverse-transcriptase polymerase chain reaction in patients with breast cancer | |
EP1355151A3 (en) | Assessing colorectal cancer | |
WO2004074301A3 (en) | Differentially expressed nucleic acids that correlate with ksp expression | |
EP1355149A3 (en) | Assessing colorectal cancer |